Roche v ANSM: the French Avastin stand-off
This article was originally published in SRA
Roche has locked horns with the ANSM, the French healthcare products regulatory agency, over the latter's plans to make Roche's Avastin available off-label for wet AMD. It's not easy to say who will emerge the winner.
Register for our free email digests: